Treatment of sensation of having heart beating unexpectedly fast with Unani medicine Mufarrah Sheikh ur Rais

Phase 3

Not yet recruiting

• Conditions: Palpitations,

• Registration Number: CTRI/2024/08/072166
• Lead Sponsor: Central Council for Research in Unani Medicine CCRUM New Delhi

Brief Summary

This study is designed as a single centric open trial in patients with **Khafqaan (Palpitation)****.**After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at every week for four weeks. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 04 weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

Composition of “Mufarrah Sheikh ur Raisâ€

| | | | | | |

| --- | --- | --- | --- | --- | --- |

|S No

Ingredients

Scientific Name

Quantity

|1.

Agar

Aquilaria agallocha Roxb.

20g.

|2.

Ilaichi Khurd

Elettaria Cardamomum

30g.

|3.

Berg Gaozaban

Borago Officinalis

50g.

|4.

Burada Sandal Surkh

Pterocarpus santalinus (Ht. Wd.)

15g.

|5.

Burada Sandal Safaid

Santalum album L.

30g.

|6.

Banslochan

Bambusa arundinaceae Retz

30g.

|7.

Behman Surkh

Salvia heamatodes L.

20g.

|8.

Tukhm Khurfa Siyah

Portulaca Oleraceae Linn

45g.

|9.

Tukhm Kahu

Lactuca sativa Linn.

45g.

|10.

Qust Shireen

Saussurea lappa, CB Clarke

20g.

|11.

Zaranbad

Curcuma Zedoaria

20g.

|12.

Sartan Sokhta

Scilla serrata ash

15g.

|13.

Gul e Surkh

Rosa damascene Herrm.

75g.

|14.

Maghz Tukhm Kharbuza

Cucumis melo L.

45g.

|15.

Maghz Tukhm Khayarain

Cucumis sativus L

45g.

|16.

Maghz Kadu Shirin

Cucurbita maxima Duch ex.Lam

45g.

|17.

Kafoor

Cinnamomum camphora

15g.

|18.

Busud Sokhta Mehlool

Corallium rubrum ash

15g.

|19.

Marwareed Mehlool

Mytilus margaritiferus

15g.

|20.

Abresham Muqarraz

Bombyx mori Cocoon

15g.

|21.

Qiwam Shakar

Saccharum officinarum

1.2kg

|22.

Rub Anar Shireen

Punica granatum

300g.

|23.

Rub Behi

Cydonia oblonga Mill

300g

|24.

Rub Seb

Malus sylvestris (L.) Mill

300g

|25.

Natroon Banjawi

 3g.

|26.

Zafran

Crocus sativa L

3.5g.

|27.

Arq Gaozaban

Borago Officinalis

40ml

|28.

Warq Nuqra

 5g.

|

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2024-07-08
• Study Start: 2024-08-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Patients of either sex in the age group of 19-60.
• Patients having Palpitations with/without Ordinary physical activity with and without any of the following symptoms/ signs: Ghabrahat Sweating Nausea Vomiting Missed Heart Beat Sensation Fullness in chest Shortness of Breath.

Exclusion Criteria

• History of any heart diseases 2.
• History of hepatic, renal disorders, diabetes mellitus, hypertension, anemia, COPD 3.
• History of thyroid dysfunction 4.
• History of hypersensitivity to any ingredient of the study drug.
• Participants with history of long term use of any other drugs such as anti-epileptic, anti-arrhythmic and anti-psychotic drugs etc.
• History of Addiction (smoking, alcohol, drugs) 7.
• Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The therapeutic efficacy will be assessed on the basis of reduction in Symptoms of Khafqaan (Palpitation).	At baseline, 1st,2nd,3rd and 4th week

Secondary Outcome Measures

Name	Time	Method
Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.	At baseline and after 4 weeks

Trial Locations

Locations (1)

Clinical Research Unit; 🇮🇳 Meerut, UTTAR PRADESH, India

Clinical Research Unit

🇮🇳Meerut, UTTAR PRADESH, India

Dr Mohd Tariq Khan

Principal investigator

9012843253

doctormtk@gmail.com